Fertility-sparing surgery for patients with stage IC2 or IC3 epithelial ovarian carcinoma: any evidence of safety?
Dimitrios NasioudisQuetrell D HeywardEmily M KoAshley F HaggertyLori CoryRobert L Giuntoli IiSarah H KimNawar A LatifPublished in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2021)
In a large cohort of patients with stage IC2/IC3 epithelial ovarian carcinoma, fertility-sparing surgery was not associated with worse overall survival. However, based on a literature review, relapse rate is approximately 20%.